We found that ghrelin treatment ameliorated CCl4- and BDL-induced liver fibrosis via inhibition of the TGFβ1/Smad3 and NF-κB pathways, as well as autophagy suppression. The gene discussed is NFKB1; the disease is Hepatic fibrosis.